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Summary
 
The differentiation of T helper (Th) cells is regulated by members of the signal transducer and
activator of transcription (STAT) family of signaling molecules. We have generated mice lack-
ing both 
 
Stat4 
 
and 
 
Stat6
 
 to examine the ability of Th cells to develop in the absence of these
 
two transcription factors. 
 
Stat4
 
,
 
 Stat6
 
2
 
/
 
2
 
 lymphocytes fail to differentiate into interleukin
(IL)-4–secreting Th2 cells. However, in contrast to 
 
Stat4
 
2
 
/
 
2
 
 lymphocytes, T cells from 
 
Stat4
 
,
 
Stat6
 
2
 
/
 
2
 
 mice produce significant amounts of interferon (IFN)-
 
g
 
 when activated in vitro. Al-
though 
 
Stat4
 
,
 
 Stat6
 
2
 
/
 
2
 
 lymphocytes produce less IFN-
 
g
 
 than IL-12–stimulated control lym-
phocytes, equivalent numbers of IFN-
 
g
 
–secreting cells can be generated from cultures of 
 
Stat4
 
,
 
Stat6
 
2
 
/
 
2
 
 lymphocytes activated under neutral conditions and control lymphocytes activated
under Th1 cell–promoting conditions. Moreover, 
 
Stat4
 
,
 
 Stat6
 
2
 
/
 
2
 
 mice are able to mount an in
vivo Th1 cell–mediated delayed-type hypersensitivity response. These results support a model
of Th cell differentiation in which the generation of Th2 cells requires Stat6, whereas a Stat4-
independent pathway exists for the development of Th1 cells.
Key words: T cell differentiation • interleukin 4 • interleukin 12 • signal transducer and 
activator of transcription
 
S
 
timulation of naive T cells results in their differentiation
into effector cells with either a Th1 or Th2 phenotype.
As Th1 cells develop, a number of genetic changes occur,
including the loss of expression of IFN-
 
g
 
R
 
b
 
 chain (1, 2),
the induced expression of a modified form of P-selectin
glycoprotein ligand 1 (3, 4), and the priming for subse-
quent secretion of high levels of IFN-
 
g
 
 and TNF-
 
b
 
 after T
cell receptor stimulation (5). Similarly, as Th2 cells de-
velop, there is a loss of expression of IL-12R
 
b
 
2 chain (6,
7), the induced expression of CCR3 (8), and the priming
to secrete a different panel of cytokines after activation, in-
cluding IL-4, IL-5, IL-10, and IL-13 (5).
Several lines of evidence have led to a paradigm of Th
cell differentiation in which IL-12–mediated activation of
signal transducer and activator of transcription (Stat)4 and
IL-4–induced activation of Stat6 are critical for the genera-
tion of Th1 and Th2 cells, respectively. Mice harboring a
disrupted gene for either IL-4 (9, 10), IL-4R
 
a
 
 (11), or
Stat6 (12–14) fail to develop Th2 cells. Similarly, mice
lacking either IL-12 (15), IL-12R
 
b
 
1 (16), or Stat4 (17, 18)
demonstrate impaired Th1 cell function and, moreover, a
propensity for T cells to develop into Th2 cells (15, 17).
Although these observations suggest that STAT proteins
are important for the differentiation of Th cell subsets, they
 
do not rule out the possibility that STAT-independent
pathways may also exist. 
 
Stat6
 
2
 
/
 
2
 
 lymphocytes are com-
pletely impaired in their ability to generate IL-4–secreting
Th2 cells, suggesting that this differentiation pathway may
be entirely dependent on Stat6. In contrast, reduced levels
of IFN-
 
g
 
 are produced by 
 
Stat4
 
2
 
/
 
2
 
 lymphocytes when cul-
tured under conditions that promote Th1 cell differentia-
tion, suggesting that Stat4 is not absolutely required for
IFN-
 
g
 
 expression. Additionally, the cytokine environment
during commitment to a Th cell lineage is clearly impor-
tant, since IL-4 confers a dominant differentiation signal
which inhibits Th1 cell differentiation even in the presence
of IL-12 (19–22). These observations suggest that although
the impaired development of Th1 cells in 
 
Stat4
 
2
 
/
 
2
 
 mice
may be due to the absence of Stat4, it may also be due in
part to the preferential outgrowth of Th2 cells in response
to IL-4–activated Stat6. Since IL-4 both activates Stat6 and
interferes with the development of Th1 cells, we generated
double-deficient mice lacking 
 
Stat4
 
 and 
 
Stat6
 
 to examine
the ability of Th1 cells to develop in the absence of these
two signaling molecules. Although lymphocytes lacking
both 
 
Stat4
 
 and 
 
Stat6
 
 fail to differentiate into IL-4–secreting
Th2 cells, they do give rise to functional IFN-
 
g
 
–secreting
Th1 cells both in vitro and in vivo.
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Materials and Methods
 
Mice. Stat4
 
,
 
 Stat6
 
2
 
/
 
2
 
 mice were generated by mating 
 
Stat4
 
2
 
/
 
2
 
and 
 
Stat6
 
2
 
/
 
2
 
 mice at the third backcross generation to Balb/c and
intercrossing the resulting compound heterozygotes. Controls
were inbred BALB/c and 129/SvJ mice, both of which gave
comparable results in each of the assays tested.
 
In Vitro Culture and Differentiation.
 
Differentiation of T cells
and assay of cytokines were performed as described (12, 17). In
brief, cells were activated with 1 
 
m
 
g/ml plate-bound anti-CD3.
Where indicated, IL-12 was added at 1 ng/ml, and anti–IFN-
 
g
 
,
anti–IL-4, and anti–IL-12 were added at 10 
 
m
 
g/ml (Genzyme
Corp., Cambridge, MA). After 1 wk in culture, cells were
washed and restimulated with plate-bound anti-CD3 for 24 h.
Supernatants were harvested, and IFN-
 
g
 
 and IL-4 production
were quantified by ELISA. Purification of CD4
 
1
 
 and CD62L
 
1
 
cells was done by positive selection using magnetic beads (Mil-
tenyi Biotec, Inc., Auburn, CA) according to the supplier’s in-
structions. CD4
 
1
 
 isolated cells were 
 
z
 
90% CD4
 
1
 
. For the purifi-
cation of naive cells, pooled spleens and lymph nodes were
depleted before positive selection with 2.4G2 (anti-CD16/32),
2.43 (anti-CD8), and M5114 (anti–I-A
 
d
 
) coupled to magnetic
beads.
 
Enzyme-linked Immunospot.
 
Cells were activated and cul-
tured as above. After 1 wk, cells were restimulated with plate-
bound anti-CD3 for 6 h and plated in dilution on anti–IFN-
 
g
 
(R4/6A2)-coated Immobilon-P membranes in a 96-well plate for
18 h. Cells were washed away, and bound cytokine was detected
with biotinylated anti–IFN-
 
g
 
 (PharMingen, San Diego, CA),
avidin–alkaline phosphatase (Sigma Chemical Co., St. Louis,
MO), and a stable BCIP/NBT mix (GIBCO BRL, Gaithersburg,
MD). Spots were developed for 30–60 min, washed with distilled
water, and counted under a dissecting microscope.
 
Delayed-type Hypersensitivity Reaction.
 
Male mice were immu-
nized with 100 
 
m
 
g DNP-KLH (Calbiochem Corp., La Jolla, CA)
emulsified in CFA (Sigma Chemical Co.), at the base of the tail.
After 6 d, footpad thickness was measured using a spring-loaded
caliper, and mice were challenged with 50 
 
m
 
g DNP-KLH in one
foot and PBS in the contralateral appendage. Footpad thickness
was measured blindly at 24 and 48 h after challenge. Specific
swelling was determined by subtracting nonspecific swelling in
the PBS-injected foot from antigen-induced swelling. At killing,
popliteal and inguinal lymph nodes were removed and stimulated
with 500 
 
m
 
g/ml DNP-KLH at a cell concentration of 10
 
6
 
/ml for
IFN-
 
g
 
 production and 2 
 
3 
 
10
 
5
 
 for proliferation assay. Prolifera-
tion assays were pulsed with [
 
3
 
H]thymidine for the last 18 h of a
72-h incubation.
 
Results and Discussion
 
To further examine the mechanism by which Stat4 and
Stat6 regulate the differentiation of Th cell subsets, we gen-
erated 
 
Stat4
 
,
 
 Stat6
 
2
 
/
 
2
 
 mice by intercrossing compound
heterozygotes. Double-deficient mice were produced at
the expected mendelian frequency and were grossly indis-
tinguishable from their control littermates. All lymphoid
organs in 
 
Stat4
 
,
 
 Stat6
 
2
 
/
 
2
 
 
 
mice had normal cellularity and
contained percentages of CD3
 
1
 
, CD4
 
1
 
, CD8
 
1
 
, and B220
 
1
 
cells comparable to that seen in control littermates (data not
shown).
Spleen cells from control, 
 
Stat4
 
2
 
/
 
2
 
, 
 
Stat6
 
2
 
/
 
2
 
, and 
 
Stat4
 
,
 
Stat6
 
2
 
/
 
2
 
 mice were activated in vitro with plate-bound
anti-CD3 in the absence of exogenous cytokines or anti-
bodies to determine their developmental potential. After 1 wk
in culture, cells were washed and restimulated with plate-
bound anti-CD3 for 24 h. Supernatants were harvested,
and IFN-
 
g
 
 and IL-4 production were quantified by ELISA.
As expected, lymphocytes from control mice secrete both
IFN-
 
g
 
 and IL-4 when activated in vitro under neutral con-
ditions (Fig. 1). Consistent with previous results (12–14,
17, 18), 
 
Stat4
 
2
 
/
 
2
 
 lymphocytes produce high levels of IL-4
but greatly reduced levels of IFN-
 
g
 
,
 
 
 
whereas
 
 Stat62/2 lym-
phocytes secrete high levels of IFN-g but no IL-4. Stat4,
Stat62/2 lymphocytes also do not produce IL-4 when acti-
vated in vitro, supporting the notion that Stat6 is essential
for the differentiation of Th2 cells. However, in contrast to
Stat42/2 lymphocytes, Stat4, Stat62/2 lymphocytes secrete
levels of IFN-g comparable to that produced by control or
Stat62/2 lymphocytes cultured under identical conditions.
Similar results were seen when cultures were either initi-
ated with purified naive T cells obtained by selection of
CD41 CD62L1 cells or when CD41 T cells were purified
after the initial 7-d culture period and subsequently restim-
ulated with anti-CD3 for 24 h (data not shown).
IL-4 signaling has a dominant effect over IL-12 stimula-
tion in determining the outcome of Th cell differentiation
(21), and the results shown in Fig. 1 suggest that the pres-
ence of IL-4 signaling through Stat6 may impair the ability
of cells to develop the Th1 cell phenotype. To test this hy-
pothesis, we attempted to recapitulate the IFN-g–secreting
phenotype of Stat4, Stat62/2 lymphocytes by activating
Stat6-expressing cells in vitro in the presence of cytokine-
specific antibodies to eliminate STAT activation. In the ab-
sence of exogenous cytokines and antibodies, in vitro–acti-
vated Stat4, Stat62/2 lymphocytes secrete more IFN-g
than  Stat42/2 lymphocytes (Figs. 1 and 2 A). When Stat42/2
lymphocytes are activated in the presence of anti–IL-4, the
levels of IFN-g produced are nearly equal to those seen in
cultures of activated Stat4, Stat62/2 lymphocytes (Fig. 2
A). Similarly, when control cells are activated in the pres-
ence of anti–IL-4 plus anti–IL-12, the levels of IFN-g pro-
duced are indistinguishable from those seen in cultures of
Figure 1. Th cell differentiation of STAT-deficient lymphocytes.
Spleen cells from mice with the indicated genotypes were activated with
plate-bound anti-CD3 in the absence of exogenous cytokines or antibod-
ies for 1 wk. Supernatants were collected 24 h after restimulation with
plate-bound anti-CD3, and cytokine levels were quantified by ELISA.1193 Kaplan et al. Brief Definitive Report
activated  Stat4, Stat62/2 lymphocytes. These results are
consistent with a recent report demonstrating IFN-g pro-
duction in the presence of neutralizing antibodies to both
IL-4 and IL-12 (23). Thus, substantial amounts of IFN-g
can be produced by activated cells lacking Stat4 as long as
Stat6 is not activated in response to IL-4 stimulation.
IFN-g has been suggested to have an important role in
priming cells for subsequent IFN-g production, although it
remains controversial whether it does so by a direct or indi-
rect mechanism. Inclusion of anti–IFN-g to primary cul-
tures of Stat4, Stat62/2 lymphocytes activated under neu-
tral conditions did not affect the amount of IFN-g produced
by these cells after restimulation with anti-CD3 (Fig. 2 B).
This is in contrast to the lower amount of IFN-g produced
by control cells after restimulation when anti–IFN-g was
added in the primary culture. These results demonstrate
that the ability of Stat4, Stat62/2 lymphocytes to acquire an
IFN-g–secreting phenotype is not driven by endogenous
IFN-g, and are consistent with studies demonstrating that
the role of IFN-g in Th1 cell differentiation is indirect, up-
regulating IL-12Rb2 expression so that cells become re-
sponsive to IL-12 stimulation (7).
IL-12 stimulation of activated T cells has been shown to
prime cells for high levels of IFN-g production after subse-
quent restimulation (24). When compared with control
lymphocytes cultured under Th1 cell–promoting condi-
tions (IL-12 plus anti–IL-4), the levels of IFN-g produced
by activated Stat4, Stat62/2 lymphocytes were decreased
four- to fivefold (Fig. 3 A). The amount of IFN-g pro-
duced by Stat4, Stat62/2 lymphocytes cultured in the pres-
ence of IL-12 does not increase over that seen when no ex-
ogenous cytokines are added (data not shown). The increased
amounts of IFN-g seen in cultures of Th1 cell–skewed
control lymphocytes relative to those seen in cultures of
Stat4, Stat62/2 lymphocytes could be the result of an in-
crease either in the number of differentiated Th1 cells or in
the amount of IFN-g produced on a per cell basis. To dis-
tinguish between these possibilities, the number of IFN-
g–secreting lymphocytes in these cultures was quantified
by enzyme-linked immunospot (ELISPOT). Spleen cells
from control mice were differentiated into Th1 cells in
vitro by activation with plate-bound anti-CD3 in the pres-
ence of IL-12 and anti–IL-4 while spleen cells from Stat42/2,
Stat62/2, and Stat4, Stat62/2 mice were activated in the
absence of exogenous cytokines and antibodies. After 1 wk
in culture, CD41 T cells were purified and restimulated with
plate-bound anti-CD3 for 6 h. Cells were then transferred
in dilution to plates containing anti–IFN-g (R4/6A2)-
coated Immobilon-P membranes at the bottom of the wells
and incubated overnight. In contrast to cultures of Stat42/2
lymphocytes where very few IFN-g–secreting cells were
detected, large numbers were seen in cultures of Th1 cell–
skewed control and unskewed Stat62/2 lymphocytes (Fig.
3 B). Strikingly, cultures of Stat4, Stat62/2 lymphocytes
Figure 2. IFN-g production by STAT-deficient lymphocytes. (A)
Spleen cells from mice with the indicated genotypes were activated with
plate-bound anti-CD3 in the presence of antibodies as indicated for 1 wk.
Cells were restimulated with plate-bound anti-CD3, and supernatants
were collected 24 h later to quantify IFN-g levels by ELISA. (B) Cells
were activated as in A in the absence (white bars) or presence (black bars) of
anti–IFN-g. Cells were restimulated with plate-bound anti-CD3, and su-
pernatants were collected 24 h later to quantify IFN-g levels by ELISA.
Figure 3. Quantification of IFN-g–secreting cells. Spleen cells from
mice with the indicated genotypes were activated with plate-bound anti-
CD3 in the presence of exogenous cytokines or antibodies as indicated
for 1 wk. (A) Cells were restimulated with plate-bound anti-CD3, and
supernatants were collected 24 h later to quantify IFN-g levels by ELISA.
(B) Cells were restimulated with plate-bound anti-CD3 for 6 h and then
transferred to plates containing anti–IFN-g (R4/6A2)-coated membranes
for 18 h. ELISPOTs were developed with a stable BCIP/NBT reagent
and counted under a dissecting microscope. Th1-skewed control cultures
had 750–1,000 IFN-g–secreting cells/105 CD41 cells.1194 Th Cell Differentiation in Mice Lacking Both Stat4 and Stat6
had numbers of IFN-g–secreting cells comparable to that
seen in cultures of Th1 cell–skewed control and unskewed
Stat62/2 lymphocytes. The spots produced in wells con-
taining Th1 cell–skewed control cells were both larger and
darker than those seen in wells containing Stat4, Stat62/2
lymphocytes, supporting the conclusion that IL-12 stimula-
tion and Stat4 activation lead to higher levels of IFN-g
production on a per cell basis rather than a substantial in-
crease in the number of differentiated Th1 cells.
Given that IFN-g–secreting cells could be generated
from  Stat4, Stat62/2 mice in vitro, we sought to determine
whether Stat4, Stat62/2 mice could mount a Th1 cell re-
sponse in vivo. To investigate this possibility, we examined
a classic Th1 cell–mediated immune response, the delayed-
type hypersensitivity (DTH) reaction. Control, Stat42/2,
and Stat4, Stat62/2 mice were immunized with 100 mg
DNP-KLH in CFA. 6 d later, mice were challenged by
footpad injection with either aqueous antigen or PBS as
control. All animals were killed 48 h after challenge, and
draining popliteal and inguinal lymph node cells were re-
moved and restimulated in vitro with antigen. Lympho-
cytes from all three genotypes of mice produced a similar in
vitro proliferative response to antigen (Fig. 4 A), demon-
strating comparable in vivo generation of antigen-specific
T cells. As expected, the levels of IFN-g produced after an-
tigen stimulation in vitro varied among the groups. Stat42/2
lymphocytes produced ,10% of the IFN-g secreted by
control cells (Fig. 4 B). Stat4, Stat62/2 lymphocytes also se-
creted less IFN-g than control cells, although the levels
were fourfold higher than that seen in cultures of Stat42/2
lymphocytes (Fig. 4 B). Finally, footpad thickness was mea-
sured before and 48 h after challenge, and specific swelling
was calculated (Fig. 4 C). Footpad swelling was signifi-
cantly different in all three groups using the Kruskal-Wallis
test (P , 0.005). Furthermore, pairwise comparisons using
the Wilcoxon-Mann-Whitney test showed that swelling in
Stat42/2 mice was significantly reduced compared with
control (P , 0.005) and Stat4, Stat62/2 mice (P , 0.05).
Thus, functional Th1 cells capable of eliciting a DTH re-
sponse can be generated in vivo in Stat4, Stat62/2 mice.
Our results demonstrate that the mechanisms that regu-
late the differentiation of Th1 and Th2 cells are not the
same. Previous studies have shown that Stat6 is essential for
the development of Th2 cells (12–14), presumably through
the transcriptional regulation of as yet unidentified genes
involved in the differentiation process. As IL-4–secreting
Th2 cells are not generated from Stat4, Stat62/2 lympho-
cytes, Stat6 is required for their generation even in the
absence of Stat4. In contrast, both Stat4-dependent and
-independent pathways appear to exist for the development
of IFN-g–producing Th1 cells. IL-12 stimulation and Stat4
activation lead to the differentiation of Th1 cells capable of
secreting large amounts of IFN-g. However, in the absence
of IL-4 and IL-12–mediated signals, the natural tendency
of CD41 Th cells is to develop into IFN-g–secreting cells.
Thus, IL-4–mediated activation of Stat6, but not IL-12–
induced activation of Stat4, results in a differentiative signal
to Th cells. Mechanistically, this would explain the obser-
vation that IL-4 signaling has a dominant effect over IL-12
stimulation in determining the outcome of Th cell differ-
entiation (21). Interestingly, a paradigm whereby the deci-
sion between two possible developmental pathways is dic-
tated by the presence or absence of one signaling cascade
occurs in other differentiative processes, including sex de-
termination. Sry expression activates a genetic program
which results in male gonadal development; female gonads
develop in its absence (25).
Although our results suggest that the ability of IL-12 to
promote Th1 differentiation may be indirect, by priming
for high levels of IFN-g production which would inhibit
Th2 development and allow the outgrowth of Th1 cells,
they do not minimize the role of IL-12 and Stat4 activation
in normal Th cell development and function. Stat4 activa-
tion is clearly involved in regulating the production of
Figure 4. DTH responses in STAT-deficient mice. (A) Draining
lymph node cells from immunized mice were stimulated in vitro in the
absence (white bars) or presence (black bars) of 500 mg/ml DNP-KLH.
Cells in round-bottomed 96-well plates were pulsed with [3H]thymidine
for the last 18 h of a 72-h incubation. (B) Supernatants from DNP-KLH–
stimulated lymph node cells were analyzed for IFN-g levels by ELISA.
(C) Specific footpad swelling of each mouse was determined by subtract-
ing nonspecific swelling in the PBS-injected foot from the DNP-KLH–
induced swelling. Each data point represents one mouse; horizontal lines
indicate averages, and results are pooled from two independent experi-
ments.1195 Kaplan et al. Brief Definitive Report
IFN-g and potentially other factors such as TNF-b that are
important in many Th1 cell–mediated responses. Never-
theless, the demonstration that functional Th1 cells can de-
velop in the absence of Stat4 has important implications for
the design of therapeutic strategies that aim to alter im-
mune function by targeting STAT proteins in vivo.
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